AcquisitionOther
Eli Lilly and Company acquired Verve Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Eli Lilly and Company -> Verve Therapeutics, Inc.
Advance gene editing medicines designed to address cardiovascular disease drivers with one-dose treatment potential.
Open source record (SEC) ↗